| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2405.4 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2218.74 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 2965.41 | 99 |
| GSM780719 | Untreated after 4 days (C1_2) | 1999.45 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2165.84 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 3338.77 | 99 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2535.25 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2331.38 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2529.28 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2585.38 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2386.88 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2695.47 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2512.3 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2370.09 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2159.01 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2424.06 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2223.57 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2218.74 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 3195.25 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2562.37 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2711.66 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2941.19 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2543.12 | 98 |